Cover
Vol. 12 No. 1 (2022)

Published: June 30, 2022

Pages: 26-36

Research Article

Assessment of Cortisol Hormonal Level and Relation with Age in Infertile Women With ICSI Outcome

Noor Mahmood 1 Rana A. Al Saadi Essra M. Al-Esawee Farah A. Mohammed 2
1High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al Nahrain University, Baghdad, Iraq.
2Medical Laboratory Techniques, Alrafidin Collage University, Baghdad, Iraq
History
  • Received: April 30, 2022
  • Accepted: May 30, 2022
  • Available Online: June 12, 2022
DOI

https://doi.org/10.28969/IJEIR.v12.i1.r3.22

Abstract

In human-assisted reproduction both partners need to be evaluated during counseling because causes of infertility are due to male factors and female factors. some body hormones play important role in fertile women and cortisol one of these hormones which is essential for normal ovulation, cortisol usually increases during the follicular phase of the menstrual cycle, play a role in the early stages of follicular development by their interaction with aromatase activity and granulose cell functions. To investigate the correlation of cortisol hormonal level in serum and in follicular fluid that relationship with age in women under Intracytoplasmic sperm injection outcome. Its randomized prospective clinical trial study performance conducting in the Higher Institute for Infertility Diagnosis and Assisted Reproductive Technologies / Al-Nahrain University, Baghdad-Iraq, during the period from November2021to June 2022. a total of Sixty-three Infertile Iraqi women, who planned to inter intrasytoplasmic sperm injection program. The blood sample and follicular fluid sample obtained from all infertile women inter intracytoplasmic sperm injection program to measure cortisol hormonal level at specific days of this study. There was increase in cortisol level in women aged between (30-40) years, So there was significant finding between cortisol level and this age group and there was increase in cortisol level in women aged < 30 years at the same day and no significant difference in cortisol level in women age more than 40. Significant differences in cortisol level appear in group of women age between (30-40) years, also the same result appears in group of women age more than > 40 years and no significant differences in cortisol level in women aged < 30. No significant differences in cortisol level in all age women group (30-40) years, <30 years ,and the women age > 40 years.

Keywords

References

  1. Ishiura, S., & Yoshida, T. (2019). Plant- based vaccines for Alzheimer's disease. Proceedings of the Japan Academy. Series B, Physical and biological sciences, 95 (6), 290– 294. https://doi.org/10.2183/pjab.95.020.
  2. Olooto, Wasiu Eniola, Amballi, Adebayo Adetola, and Banjo, Taiwo Abayomi, A review of Female Infertility; important etiological factors and management 2012, J. of Microbiology and Biotechnology, 2, (3), 379-385. DOI: http://dx.doi.org/10.3329/jom.v13i2.12757
  3. Agboola, A., (2004) Textbook of Obstetrics and Gynaecology, Heinman Educational Books, Ibadan, VOL. 1, pp.174- 176.
  4. Gonçalves, P.B., Portela, V.M., Ferreira, R. and Gasperin, B.G., Role of angiotensin II on follicle development and ovulation 2010. J. Anim. Reprod., 7, 140–5
  5. De Souza, M. J., Miller, B. E., Loucks, A. B., Luciano, A. A., Pescatello, L. S., Campbell, C. G., & Lasley, B. L. (1998). High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. The Journal of clinical endocrinology and metabolism, 83 (12), 4220–4232. https://doi.org/10.1210/jcem.83.12.5334
  6. Park, H. J., Lyu, S. W., Seok, H. H., Yoon, T. K., & Lee, W. S. (2015). Anti-Müllerian hormone levels as a predictor of clinical pregnancy in in vitro fertilization/intracytoplasmic sperm injection- embryo transfer cycles in patients over 40 years of age. Clinical and experimental reproductive medicine, 42 (4), 143–148. https://doi.org/10.5653/cerm.2015.42.4.143
  7. Fisch, J. D., Keskintepe, L., & Sher, G. (2008). Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure. Fertility and sterility, 89 (2),342–347. https://doi.org/10.1016/j.fertnstert.2007.03.0 04
  8. Andersen C. Y. (2002). Possible new mechanism of cortisol action in female reproductive organs: physiological implications of the free hormone hypothesis. The Journal of Endocrinology, 173 (2), 211– 217. https://doi.org/10.1677/joe.0.1730211
  9. Jones, M. R., & Goodarzi, M. O. (2016). Genetic determinants of polycystic ovary syndrome: progress and future directions. Fertility and sterility, 106 (1), 25–32. https://doi.org/10.1016/j.fertnstert.2016.04.0 40
  10. El Hayek, S., Bitar, L., Hamdar, L. H., Mirza, F. G., & Daoud, G . Poly Cystic Ovarian Syndrome: An Updated Overview 2016. J. Frontiers in physiology, 7, 124. https://doi.org/10.3389/fendo.2021.662725
  11. Barbieri RL., Clinical manifestations of polycystic ovary syndrome in adults 2017. https://www.uptodate.com/home.
  12. Alzaidi, Z., Yildiz, Ş.M., Saatçi, Ç. et al. The effect of cytokine leukemia-inhibitory factor (LIF) and interleukin-11 (IL-11) gene expression on the primary infertility related to polycystic ovary syndrome, Tubal factor, and Unexplained infertility in Turkish women. Egypt J Med Hum Genet 22, 85 (2021). https://doi.org/10.1186/s43042-021-00201-9
  13. Vilar, L., Abucham, J., Albuquerque, J. L., Araujo, L. A., Azevedo, M. F., Boguszewski, C. L., Casulari, L. A., Cunha Neto, M. B. C., Czepielewski, M. A., Duarte, F. H. G., Faria, M. D. S., Gadelha, M. R., Garmes, H. M., Glezer, A., Gurgel, M. H., Jallad, R. S., Martins, M., Miranda, P. A. C., Montenegro, R. M., Musolino, N. R. C., … Bronstein, M. D. (2018). Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism. Archives of endocrinology and metabolism, 62 (2), 236–263. https://doi.org/10.20945/2359399700000003 2
  14. Raff, H., & Carroll, T. (2015). Cushing's syndrome: from physiological principles to diagnosis and clinical care. The Journal of Physiology, 593 (3), 493–506. https://doi.org/10.1113/jphysiol.2014.282871
  15. Michels A, Michels N. Addison disease: early detection and treatment principles. Am Fam Physician. 2014 Apr 1;89 (7):563-8. PMID: 24695602.
  16. Ellen Anckaert, Johan Schiettecatte, Marleen Mees, Johan Smitz, Clinical Validation of a Fully Automated 17β- Estradiol and Progesterone Assay (VIDAS®) for Use in Monitoring Assisted Reproduction Treatment 2002, Clinical Chemistry and Laboratory Medicine, 40, (8): 824-31 https://doi.org/10.1515/CCLM.2002.143
  17. Gan, S. D., & Patel, K. R. (2013). Enzyme immunoassay and enzyme-linked immunosorbent assay. The Journal of Investigative Dermatology, 133 (9), e12. https://doi.org/10.1038/jid.2013.287
  18. Seeman, T. E., & Robbins, R. J. (1994). Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocrine Reviews, 15 (2), 233–260. https://doi.org/10.1210/edrv-15-2-233
  19. Nicolson, N., Storms, C., Ponds, R., & Sulon, J. (1997). Salivary cortisol levels and stress reactivity in human aging. The Journal of Gerontology. Series A, Biological sciences and medical sciences, 52 (2), M68–M75. https://doi.org/10.1093/gerona/52a.2.m68
  20. Deuschle, M., Gotthardt, U., Schweiger, U., Weber, B., Körner, A., Schmider, J., Standhardt, H., Lammers, C. H., & Heuser, I. (1997). With aging in humans, the activity of the hypothalamus-pituitary-adrenal system increases, and its diurnal amplitude flattens. Life sciences, 61 (22), 2239–2246. https://doi.org/10.1016/s00243205 (97) 00926-0 .